Call the Office of Patient Recruitment at 800-411-1222 to speak with one of our Information Specialists.
For those who are deaf, hard-of-hearing, or speech impaired, the Federal Relay Service provides free telecommunications relay services (TRS).
Se habla español.
Patients with Unresectable Fibrolamellar Hepatocellular Carcinoma (FLC)
Researchers at the National Institutes of Health are studying the use of an antibiotic called vancomycin treatment for unresectable Fibrolamellar Hepatocellular Carcinoma (FLC). FLC most often occurs in young people who have no history of liver disease. Researchers think gut bacteria may affect liver cancer, this antibiotic will help alter the gut bacteria and may be beneficial for this type of cancer.
- Medical history and physical exam
- Take vancomycin 3 times a day
- Keep a medication diary
- Have a liver biopsy before treatment
- Follow-up visit a month after treatment
Who Can Particpate
- Patients age 18 years or older
- Diagnosed with unresectable Fibrolamellar Hepatocellular Carcinoma
- Patient unresponsive to previous treatment
Location: The NIH Clinical Center, America's Research Hospital is located on the Metro red line (Medical Center stop) in Bethesda, Maryland.
For more information:
NIH Clinical Center Office of Patient Recruitment
800-877-8339 TTY / ASCII
Se habla español
Or go online:
Refer to study # 19-C-0125
Department of Health and Human Services
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
NOTE: PDF documents require the free Adobe Reader.
This page last updated on 02/25/2020